Article
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
8 Jan 2019
Abstract excerpt
Cancer sequencing studies have implicated regulators of pre-mRNA splicing as important disease determinants in acute myeloid leukemia (AML), but the underlying mechanisms have remained elusive. We hypothesized that "non-mutated" splicing regulators may also play a role in AML biology and therefore conducted an in vivo shRNA screen in a mouse model of CEBPA mutant AML. This has led to the identification of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
